Xarelto Bleeding Lawsuits - Defective Drugs

Topic Image: 
Xarelto (rivaroxavan) is a blood thinner that is often prescribed as an alternative to warfarin. Unfortunately, the popular drug is known to cause serious bleeding events that are often fatal and have left survivors with permanent injuries. Unlike warfarin, Xarelto has no antidote or reversal agent, so when bleeding starts there is no way for doctors to stop it.

Why is Xarelto Prescribed?

Xarelto is prescribed to:

  • Reduce stroke risk due to blood clots that can occur in nonvalvular atrial fibrillation
  • Prevent blood clots from forming after hip or knee replacement
  • Treat certain kinds of existing blood clots, such as deep vein thrombosis (DVT) and pulmonary embolus (PE), and prevent them from forming again

How is Xarelto Different?

Xarelto is the second most prescribed drug for atrial fibrillation. It is popular because it is more convenient to use than older types of blood thinning drugs such as warfarin. Older blood thinners require monitoring, meaning frequent blood tests, to adjust for the proper dose. There are also dietary restrictions because vitamin K reverses the action of drugs like warfarin.

Xarelto is marketed as a once a day pill that does not require monitoring or dietary restrictions.

While both drugs are known to cause bleeding events, there is an antidote to warfarin so doctors can stop the bleeding. There is no antidote or reversal agent for Xarelto, so when a bleeding event occurs, doctors are helpless to stop it.

Xarelto is responsible for tens of thousands of otherwise avoidable bleeding events, and its efficacy is questionable.

Xarelto Injuries

Xarelto can cause:

  • Abdominal bleeding
  • Brain hemorrhage
  • Abnormal liver function
  • Reduced platelet levels

Xarelto bleeding event can be fatal. Those who survive can suffer from permanent injuries.

Profits Over Safety

The Office of Prescription Drug Promotion (OPDP) of the FDA sent a letter on June 6, 2013 to Xarelto maker, Johnson & Johnson, warning that its direct-to-consumer (DTC) print advertisement for Xarelto was “false or misleading because it minimizes the risks associated with Xarelto and makes a misleading claim.”

If you have suffered a serious bleeding event while taking Xarelto, or if someone you love died from Xarelto-related bleeding, you can learn more about your rights and how you can hold the pharmaceutical company responsible for your losses by searching our directory to find a lawyer near you.